60 Day FRN

Att. B1 - Published 60-Day FRN.pdf

[NCEZID] Adverse Health Outcomes Associated with Medical Tourism Surveillance System

60 Day FRN

OMB:

Document [pdf]
Download: pdf | pdf
65358

Federal Register / Vol. 89, No. 154 / Friday, August 9, 2024 / Notices

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–17765 Filed 8–8–24; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–24HD; Docket No. CDC–2024–
0054]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Adverse Health
Outcomes Associated with Medical
Tourism Surveillance System. This
information collection project will help
CDC detect outbreaks and trends in
cases to identify prevention measures
and improve awareness of risks
associated with medical tourism.
DATES: CDC must receive written
comments on or before October 8, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0054 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.

ddrumheller on DSK120RN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

19:21 Aug 08, 2024

Jkt 262001

Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

Proposed Project
Adverse Health Outcomes Associated
with Medical Tourism Surveillance
System—New—National Center for
Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Millions of Americans travel abroad
each year to get medical care. This
practice of medical tourism is
increasing, with even some U.S.-based
health insurance companies sending
patients abroad for medical care.
Medical tourism has been associated
with a variety of adverse health
outcomes including serious infection,
importation of antibiotic-resistant
pathogens to the United States, and
death. Outbreaks among medical
tourists can be difficult to identify for
many reasons. Complications from
treatment(s) and procedure(s) obtained
abroad are underreported by U.S.
healthcare facilities. Jurisdictions
throughout the United States have
varying policies on reporting medical
tourism-related adverse health events to
CDC that can lead to underreporting
from some jurisdictions. Infections
acquired from health care abroad may
not be locally or nationally reportable.
Currently, there is no national
surveillance system or mechanism for
states to link cases between jurisdictions
for medical tourism-related adverse
health outcomes. This makes it difficult
to identify patients with exposures
linked to the same clinic or provider
abroad since they will be returning to
different parts of the United States.
Collaboration with state and local
health departments is essential to detect
outbreaks, and as a federal entity, CDC
can fulfill this role. The information
collected through this surveillance
system will help CDC detect outbreaks
and trends in cases to identify
prevention measures and improve
awareness of risks associated with
medical tourism. State and local health
departments will conduct surveys and
send them electronically to CDC. Data
collected will be stored in an electronic
database and will be extracted for
further analysis.
CDC requests OMB approval for an
estimated 438 annual burden hours.
There are no costs to respondents other
than their time.

E:\FR\FM\09AUN1.SGM

09AUN1

65359

Federal Register / Vol. 89, No. 154 / Friday, August 9, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name

State/Local Health department staff

Form 1 Medical Tourism Case Intake Form (Part B-Medical Chart
Abstraction).
Form 1 Medical Tourism Case Intake Form (Part A-Interviews).

Ill persons who have experienced
an adverse health outcome related to medical tourism.
Ill persons who have experienced
an adverse health outcome related to medical tourism.
Total ..........................................

5/60

63

750

1

10/60

125

Form 2 Medical Tourism Enhanced
Surveillance Form.

500

1

30/60

250

..........................................................

........................

..........................

........................

438

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10147 and
CMS–10905]

Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:

The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of

SUMMARY:

ddrumheller on DSK120RN23PROD with NOTICES1

Total
burden
hours

15

[FR Doc. 2024–17764 Filed 8–8–24; 8:45 am]

19:21 Aug 08, 2024

Average
burden per
response
(in hours)

50

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.

VerDate Sep<11>2014

Number of
responses per
respondent

Number of
respondents

Type of respondents

Jkt 262001

information technology to minimize the
information collection burden.
DATES: Comments must be received by
October 8, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to http://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:

William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:

Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

CMS–10147 Medicare Drug Coverage
and Your Rights
CMS–10905 Service Level Data
Collection for Initial Determinations
and Appeals
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Revision of a currently
approved information collection; Title
of Information Collection: Medicare
Drug Coverage and Your Rights; Use:
Section 423.562(a)(3) and an associated
regulatory provision at
§ 423.128(b)(7)(iii) require that Part D
plan sponsors’ network pharmacies
provide Part D enrollees with a printed
copy of our standardized pharmacy
notice ‘‘Medicare Drug Coverage and
Your Rights’’ (hereafter, ‘‘notice’’) if an
enrollee’s prescription cannot be filled.
The purpose of this notice is to
provide enrollees with information
about how to contact their Part D plans
to request a coverage determination,
including a request for an exception to
the Part D plan’s formulary. The notice
reminds enrollees about certain rights

E:\FR\FM\09AUN1.SGM

09AUN1


File Typeapplication/pdf
File Modified2025-06-27
File Created2024-08-13

© 2025 OMB.report | Privacy Policy